Advertisement

Langenbecks Archiv für Chirurgie

, Volume 379, Issue 6, pp 317–320 | Cite as

Welche berechtigung hat die arterielle chemotherapie in der behandlung von kolorektalen lebermetastasen?

  • M. Lorenz
  • A. Encke
Editorial
  • 16 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Advanced Colorectal Cancer Meta-Analysis Project (1992) Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: Evidence in terms of response rate. J Clin Oncol 10:869–903Google Scholar
  2. 2.
    Allen-Mersh TG, Earlam S, Fordy C, Abrams K (1994) Continuous hepatic artery floxuridine (FUDR) infusion prolongs overall and normal-quality survival in colorectal liver metastasis (CLM) patients. Proceedings of the ASCO 13:593 (Abstract)Google Scholar
  3. 3.
    Ardalan B, Chua L, Tian E, Reddy R, Sridhar K, Benedetto P, Richman S, Legaspi A, Waldman S, Morrell L, Feun L, Savaraj N, Livingstone A (1991) A phase II study of weekly 24-hour infusion with high dose fluorouracil with leucovorin in colorectal carcinoma. J Clin Oncol 4:625–630Google Scholar
  4. 4.
    Balch CM, Urist MM, Soong S-J, McGregor M (1983) A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 198:567–573Google Scholar
  5. 5.
    Boese-Landgraf J, Albrecht D, Diermann J, Weber B (1994) 10 years experience with regional chemotherapy for liver metastases. J Cane Res Clin Oncol 120 [Suppl]: R 99, Abstract P2.05.03Google Scholar
  6. 6.
    Campbell KA, Burns RC, Sitzman JV, Lipsett PA, Grochow LB, Niederhuber JE (1993) Regional chemotherapy devices: effect of experience and anatomy on complications. J Clin Oncol 11:822–826Google Scholar
  7. 7.
    Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206:685–693Google Scholar
  8. 8.
    Curley SA, Hohn DC, Roh MS (1990) Hepatic artery infusion pumps: cannulation techniques and other surgical considerations. Langenbecks Arch Chir 375:119–124Google Scholar
  9. 9.
    Curley SA, Roh MS, Chase JL, Hohn DC (1993) Adjuvant hepatic arterial chemotherapy after curative resection of colorectal liver metastases. Am J Surg 166:743–748Google Scholar
  10. 10.
    Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Come S, Steel G, Frei E (1978) A clinical pharmacological evaluation of hepatic arterial infusion of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res 38:3784–3792Google Scholar
  11. 11.
    Hodgson WJB, Friedland M, Ahmed T, Mittelman A, Berman H, Katz S, Morgan J, Byrne D (1986) Treatment of colorectal hepatic metastases by intrahepatic chemotherapy alone or as an adjuvant to complete or partial removal of metastatic disease. Ann Surg 203:420–425Google Scholar
  12. 12.
    Herrmann G, Lorenz M, Kirkowa-Reimann M, Hottenrott C, Hübner K (1987) Morphological changes after intra-arterial chemotherapy of the liver. Hepatogastroenterol 34:5–9Google Scholar
  13. 13.
    Hohn D, Melnick J, Stagg R et al (1985) Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol 3:98–102Google Scholar
  14. 14.
    Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ (1989) A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial. J Clin One 7:1649–1654Google Scholar
  15. 15.
    Jochheim C, Linscheid M, Löffler TM (1991) Bestimmung der Gewebekonzentrationen von 5-Fluorouracil nach intraarterieller Injektion in normalem Lebergewebe und Lebermetastasen. Tumordiagn Ther 12:55–59Google Scholar
  16. 16.
    Kemeny N, Daly J, Reichman B, Geller N, Borer J, Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Intern Med 107:459–465Google Scholar
  17. 17.
    Kemeny N, Seiter K, Niedzwiecki D, Chapman D, Sigurdson E, Cohen A, Botet J, Oderman P, Murray P (1992) A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 69:327–334Google Scholar
  18. 18.
    Kemeny N, Seiter K, Conti JA, Cohen A, Bertino JR, Sigurdson ER, Botet J, Chapman D, Mazumdar M, Budd AJ (1994) Hepatic arterial floxuridine and leucovorin for uniresectable liver metastases from colorectal cancer. Cancer 73:1134–1142Google Scholar
  19. 19.
    Link KH, Kreuser ED, Safi F, Ullrich J, Schalhorn A, Schmoll E, Beget HG (1993) Die intraarterielle Chemotherapie mit 5-FU und Folinsäure (FA, Rescuvolin®) im Therapiekonzept bei nicht resektablen kolorektalen Lebermetastasen. Ein Vergleich von 5-FU/FA i. v. vs. 5-FU/FA i. v. vs. 5-FUDR i. a. oder 5-FUDR i. a.+i. v. Tumordiagn Ther 14:224–231Google Scholar
  20. 20.
    Lorenz M, Hottenrott C, Inglis R, Kirkowa-Reimann M (1989) Prevention of extrahepatic disease during intraarterial floxuridine of colorectal liver metastases by simultaneous systemic 5-fluorouracil treatment? A prospective multicenter study. Jpn J Cane Chemoth 16:3662–3671Google Scholar
  21. 21.
    Lorenz M, Herrmann G, Kirkowa-Reimann M, Rauber K, Herrhausen T, Henne T, Hottenrott C (1989) Temporary chemoembolization of colorectal liver metastases with degradable starch microspheres. Europ J Surg Oncol 15:453–462Google Scholar
  22. 22.
    Lorenz M, Hottenrott C, Maier P, Reimann M, Inglis R, Encke A (1992) Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: Influence of modulation with leucovorin. Sem in Oncol 19 [Suppl 3]: 163–174Google Scholar
  23. 23.
    Lorenz M, Hottenrott C, Encke A (1993) Adjuvante regionale Chemotherapie nach Resektion von Lebermetastasen kolorektaler Primärtumoren. Zentralbl Chir 118:279–289Google Scholar
  24. 24.
    Martin JK, O'Connel MJ, Wieand HS, Fitzgibbons RJ, Mailliard JA, Rubin J, Nagorney DM, Tschetter LK, Krook JE (1990) Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 125:1022–1026Google Scholar
  25. 25.
    Moriya Y, Sugihara K, Hojo K, Makuuchi M (1991) Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer: A pilot study. Eur J Surg Oncol 17:519–525Google Scholar
  26. 26.
    Müller JM, Schmidt A, Strauss JM, Zieren HU (1991) Resektion von Lebermetastasen kolorektaler Karzinome. Anspruch and Wirklichkeit. Dtsch Mod Wochenschr 116:681–688Google Scholar
  27. 27.
    Patt YZ, McBride CM, Ames FC, Claghorn LJ, Cleary KB, Boddie AW Charnsangavej C, Mavligit GM (1987) Adjuvant perioperative hepatic arterial mitomycin C and floxuridine combined with surgical resection of metastatic colorectal cancer in the liver. Cancer 59:867–873Google Scholar
  28. 28.
    Raab R (1992) Adjuvante Behandlung nach Leberresektion mit dem monoklonalen Antikörper 17-1 A. Vortrag vom 16. 10. 1992 auf dem Symposium Regionale Tumortherapie: Leber-Extremitäten-Peritoneum in Frankfurt am MainGoogle Scholar
  29. 29.
    Riesener KP, Winkeltau G, Klemm M, Schumpelick V (im Druck) Chirurgische Therapie von Lebermetastasen. Langenbecks Arch ChirGoogle Scholar
  30. 30.
    Rougier P, Laplanche A, Hay JM, Ollivier JM, Escat J, Salmon R, Julien M, Roullet J-C, Gallot D, Gouzi JL, Paillier JL, Elisa D, Lacaine F, Roos S, Rotman N, Luboinski M, Lasser P (1992) Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 10:112–118Google Scholar
  31. 31.
    Safi F, Bitmer R, Roscher R, Schuhmacher K, Gans W, Beger GH (1989) Regional chemotherapy for hepatic metastases of colorectal cancer (continuous intraarterial versus continuous intraarterial/intravenous therapy). Results of a controlled clinical trial. Cancer 64:379–387Google Scholar
  32. 32.
    Schalhorn A, Kühl M (1992) Clinical pharmacokinetics of fluorouracil and folinic acid. Sem Oncol 19 [Suppl 3]:82–92Google Scholar
  33. 33.
    Stagg RJ, Venook AP, Chase JL et al (1991) Alternating hepatic intra-arterial floxuridine and fluorouracil: A less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst 83:423–428Google Scholar
  34. 34.
    Wagman JS, Kemeny MM, Leong L, Terz JJ, Hill LR, Beatty JD, Kokal WA, Riihimaki DU (1990) A prospective randomized evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 8:1885–1893Google Scholar
  35. 35.
    35.Watkins E (1963) Chronometric infusor: an apparatus for protracted ambulatory infusion therapy. N Eng J Med 269:850–885Google Scholar
  36. 36.
    Watkins E, Khazei AM, Nahra KS (1970) Surgical basis for arterial infusion chemotherapy of disseminated carcinoma of the liver. Surg Gynecol Obstet 130:581–605Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • M. Lorenz
    • 1
  • A. Encke
    • 1
  1. 1.Klinik für Allgemeinchirurgie der Johann Wolfgang Goethe-UniversitätFrankfurt/Main

Personalised recommendations